Rising Biosciences (Rising Biosciences) Days Payable : 0.00 (As of . 20)

View and export this data going back to . Start your Free Trial

What is Rising Biosciences Days Payable?

Rising Biosciences's average Accounts Payable for the three months ended in . 20 was $0.00 Mil. Rising Biosciences's Cost of Goods Sold for the three months ended in . 20 was $0.00 Mil.

The historical rank and industry rank for Rising Biosciences's Days Payable or its related term are showing as below:

RBII's Days Payable is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 88.69
* Ranked among companies with meaningful Days Payable only.

Rising Biosciences's Days Payable stayed the same from . 20 (0.00) to . 20 (0.00). stayed the same

Rising Biosciences Days Payable Historical Data

The historical data trend for Rising Biosciences's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rising Biosciences Days Payable Chart

Rising Biosciences Annual Data

Trend

Days Payable

Rising Biosciences Quarterly Data

Days Payable

Competitive Comparison of Rising Biosciences's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Rising Biosciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rising Biosciences's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rising Biosciences's Days Payable distribution charts can be found below:

* The bar in red indicates where Rising Biosciences's Days Payable falls into.

Rising Biosciences Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Rising Biosciences's Days Payable for the fiscal year that ended in . 20 is calculated as

	Days Payable (A: . 20 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: . 20 )	+	Accounts Payable (A: . 20 ))	/	count )	/	Cost of Goods Sold (A: . 20 )	*	Days in Period
=	( (	+	)	/	1 )	/		*	365
=	0					/		*	365
=	N/A

Rising Biosciences's Days Payable for the quarter that ended in . 20 is calculated as:

	Days Payable (Q: . 20 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: . 20 )	+	Accounts Payable (Q: . 20 ))	/	count )	/	Cost of Goods Sold (Q: . 20 )	*	Days in Period
=	( (	+	)	/	1 )	/		*	365 / 4
=	0					/		*	365 / 4
=	N/A

Rising Biosciences Days Payable Related Terms

Thank you for viewing the detailed overview of Rising Biosciences's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Rising Biosciences (Rising Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rising Biosciences Inc (GREY:RBII) » Definitions » Days Payable

Traded in Other Exchanges

N/A

Address

1180 Cleveland Road, Sandusky, OH, USA, 44870

Website

http://www.risingbiosciences.com

Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.